Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Tuesday July 9

Poster Exhibitions,, f.1

TuPeC487o The impact of STARHS "detuned assay" results
on HIV incidence calculations in an ongoing
cohort of men who have sex with men (MSM) in
Vancouver
S L Martindale, D Cook, A E Weber, M L Miller,
K Chan, K ]P Craib, R S Hogg (Canada)
TuPeC4871 Higher incidence of comunity acquired
pneumonia in HIV infected patients than in
general population in HAART era
M Velasco, JA Satue, J E Losa, A Espinosa,
A Delgado-Iribarren, V Castilla (Spain)
TuPeC4872 Risk of HIV infection attributable to oral sex
among MSM and in the MSM population: the HIV
Oral Transmission (HOT) Study
K Page-Shafer, D Osmond, J Ball, A Hernandez,
S Shiboski, C Shiboski, W McFarland, J Klausner,
D Greenspan, J Dilley (United States)
TuPeC4873 HIV seroincidence in a population of men having
sex with men from Buenos Aires, Argentina
M Avila', M Vignoles', S Maulen', H W Sheppard,
S Sosa Estani, M A Pando', L Martinez Peralta',
M Weissenbacher' (Argentina; 2United States)
TuPeC4874 Evaluation of possible bias due to truncation of
annual HIV incidence estimates among persons
undergoing repeat diagnostic testing
A N Burchell, R S Remis, P Corey, C Major,
L Calzavara, TMyers, P Millson, E Wallace,
and the Polaris Study Team (Canada)
TuPeC4875 Statistical modelling and estimation of HIV
incidence in Spanish childbearing age women
A Esteve', P Yan2, J Casabona', J Castilla'
('Spain; 2Canada)
TuPeC4876 HIV/AIDS cases estimation and importance of the
incubation period
A Gederlini, L Villarroel, G Marshall, A Arredondo,
E Ortiz (Chile)
TuPeC4877 Estimating time since HIV-1 infection by
determining end-point antibody titers in S/LS
assays
A M Sill, FR Cleghorn', N Jack2, H Smith2, H Zink',
K Kreisel, WA Blattner', C Bartholomew,
N T Constantine' (United States; 2Trinidad and
Tobago)
TuPeC4878 Performance of the new COBAS Ampliprep
system for fully automated ultrasensitive
measurements of plasma HIV-1 RNA
J Izopet, J Boineau, C Souyris, K Saune,
M Miedouge, C Pasquier, J Puel (France)
TuPeC4879 HIV-1 antibody testing of dried blood spot (whole
blood): a preliminary field evaluation of HIV kits
in Botswana
R Cheingsong', S Gaolekwe, W Kalake2,
T Kenyon2, M Rayfield', K Bond', J Mei', L Xia'
('United States; 2Botswana)
TuPeC488o Do topical microbicides interfer with Chlamydia
trachomatis (CT) or Neisseria gonorrhoeae (NG)
testing?
P Wasinrapee, PH Kilmarx, 0 Suksripanich,
T Chaowanachan, S Chaikummao, I Thongpun,
N L Young (Thailand)
TuPeC4881 Ultra-low detection of HIV p24 antigen using
immuno-PCR
N T Constantine, I Barletta, E Feng, D C Edelman,
WE Highsmith (United States)
TuPeC4882 Determination of accuracy and feasibility of an inhouse IFA to detect antibodies to HIV-i in Kenya
M K Kiptoo, S Mpoke, N Kobayashi, T Amano,

FA Okoth (Kenya)

TuPeC4883 Evaluation of HIV test kits in use in Indonesia
J Kumalawati', N Sukartini', A S Aziz,
FS Wignall'P, M Chow2, E Donegan2
('Indonesia; 2United States)
TuPeC4884 Use of rapid HIV test kits in Indonesia
N Sukartini', Kumalawati, A S Aziz, I M Chow2,
FS Wignall, E Donegan2 0ndonesia; 2United
States)
TuPeC4885 Absence of p31 band identifies persons with
recent H IV seroconversion
FM Hecht (United States)
TuPeC4886 Feasibility of a rapid immunochromatography
test format for the detection of antibodies to HIV1 in urine
J Kaeller, JA Hasan, R W Mink, D A jacobsen,
T D Gottfried (United States)
TuPeC4887 Analysis of RNA extraction methods for the
detection of HIV genome in needle-retained
blood by the polymerase chain reaction (PCR)
D M Lima, B A L Fonseca (Brazil)
TuPeC4888 Detection of HIV genome in needle-retained
blood by the polymerase chain reaction (PCR)
and correlation with H IV viral load
D M Lima, 1 KB Colares, B A L Fonseca (Brazil)
TuPeC4889 Translation of the complete system of serological
HIV-diagnosis into a rapid format using novel
technologies
H Repke, S Nicolaus, 0 Lettau, G Vetter, V Wong
(Germany)
TuPeC489o Evaluation of 'InstantScreen', an ultra-rapid
HIV1/2 assay based upon novel tecnhologies for
the detection of the HIV antibodies
R S De Souza', L R Motto', V Wong2, 0 GomezMarin3, C Mitchel/P, H Repke2
('Brazil; 2Germany; 3United States)
TuPeC4891 Genetic diversity in the gp41 region of HIV-1
strains representative for the genetic diversity in
Cameroon: implications for diagnosis
FA Aghokeng', L Ewane', B Awazi', A Nanfack,
L Vergne2, F Liegeois2, E Deloporte2, M Peeters2,
L Zekeng ('Cameroon; 2France)
TuPeC4892 An assessment of two rapid and two routine HIV
EIAs using oral fluid (Oraquick), whole blood
(Abbott Determine HIV1/2), urine (GAC) or serum
as diagnosic sample from a clade C restricted
epidemic
D F York P Kiepiela, A N Smith (South Africa)
TuPeC4893 The heat-dissociated p24 antigen assay:
improved sensitivity for acute HIV infection
diagnosis
S A Fiscus A A Cachafeiro, C B Hicks, J J Eron,
CD Pilcher (United States)
TuPeC4894 Adapting methodologies to socio-cultural
differences: the experience of the Axios
Mobilization Methodology
H Houlihan', A Reeler, V Fages', A Magalla3,
C Ouedraogo4, I Sabas (France; 2United
Kingdom; 3Tanzania; 4Burkina Faso; sireland)
TuPeC4895 Self-reported clinical signs and symptoms in the
prognostic assessment of severe
immunodeficiency in men with subtype C HIV
infection in Harare, Zimbabwe
R N Machekano', M T Bassett, W McFarland',
D A Katzenstein' (United States; 2Zimbabwe)
TuPeC4896 Demystifying community assessment of an
elusive drug problem: a Philippine experience
M I Melar, C Abella, R Aldana (Philippines)

Tuesday

XIV International AIDS Conference BARCELONA - JULY 7-12

ill